跳至主要内容
临床试验/NCT00743119
NCT00743119已完成2 期

Comparison of the Analgesic Effects of Dronabinol and Smoked Marijuana in Daily Marijuana Smokers

New York State Psychiatric Institute1 个研究点 分布在 1 个国家目标入组 34 人开始时间: 2008年6月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
2 期
状态
已完成
入组人数
34
试验地点
1
主要终点
Pain Tolerance

研究概览

简要总结

The following study is designed to determine the analgesic efficacy of smoked marijuana (0, 1.98, and 3.56% THC) and oral THC (0, 10, and 20 mg) in the Cold-Pressor Test (CPT), a laboratory model of pain which has predictive validity for clinical use of analgesics. Oral THC (dronabinol) is known to have a slower onset and longer duration of action compared with smoked marijuana. Therefore, the analgesic effects of oral THC is expected to peak later and last longer than effects produced by smoked marijuana.

详细描述

Laboratory animal studies have demonstrated the analgesic effects of drugs which act on the cannabinoid system, however, these effects have et to be clearly elucidated in humans. To better understand the potential clinical application of cannabinoids for pain management, the following study is designed to determine the analgesic efficacy of smoked marijuana (3.56% THC) and oral THC (20 mg) in the Cold-Pressor Test (CPT), a laboratory model of pain which has predictive validity for clinical use of analgesics. Non-treatment seeking marijuana smokers will be recruited for a five-session study during which the analgesic, subjective, and physiologic effects of cannabinoids will be evaluated. Determining the efficacy of cannabinoids in an experimental model of pain will provide important endpoints (i.e., dose, route of administration, time course) or this effect to further investigate the potential role for clinical use of smoked marijuana and/or oral THC as analgesics.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Crossover
主要目的
Other
盲法
Double (Participant, Investigator)

盲法说明

Placebo-controlled, double-blind

入排标准

年龄范围
21 Years 至 45 Years(Adult)
性别
Female
接受健康志愿者

入选标准

  • Adults between the ages of 21-45
  • Current marijuana use
  • Able to perform study procedures
  • Women practicing an effective form of birth control

排除标准

  • Female subjects who are currently pregnant or breastfeeding
  • Current,repeated illicit drug use other than marijuana
  • Presence of significant medical illness
  • History of heart disease
  • Request for drug treatment
  • Current parole or probation
  • Recent history of significant violent behavior

研究组 & 干预措施

Placebo + inactive marijuana (0% THC)

Placebo Comparator

Participants received placebo capsules and smoked inactive marijuana (0% THC) on 1 of 5 outpatient sessions in randomized order.

干预措施: Placebo capsules (Drug)

Placebo + inactive marijuana (0% THC)

Placebo Comparator

Participants received placebo capsules and smoked inactive marijuana (0% THC) on 1 of 5 outpatient sessions in randomized order.

干预措施: Inactive marijuana (0% THC) (Drug)

Dronabinol 10 mg + Marijuana (0% THC)

Experimental

Participants received low dose Dronabinol + inactive marijuana (0% THC) on 1 of 5 outpatient sessions in randomized order.

干预措施: Inactive marijuana (0% THC) (Drug)

Dronabinol 10 mg + Marijuana (0% THC)

Experimental

Participants received low dose Dronabinol + inactive marijuana (0% THC) on 1 of 5 outpatient sessions in randomized order.

干预措施: Low dose Dronabinol (Drug)

Dronabinol 20 mg + Marijuana (0% THC)

Experimental

Participants received High dose Dronabinol + inactive marijuana (0% THC) on 1 of 5 outpatient sessions in randomized order.

干预措施: Inactive marijuana (0% THC) (Drug)

Dronabinol 20 mg + Marijuana (0% THC)

Experimental

Participants received High dose Dronabinol + inactive marijuana (0% THC) on 1 of 5 outpatient sessions in randomized order.

干预措施: High dose Dronabinol (Drug)

Placebo + Marijuana (1.98% THC)

Experimental

Participants received placebo + low THC marijuana (1.98% THC) on 1 of 5 outpatient sessions in randomized order.

干预措施: Placebo capsules (Drug)

Placebo + Marijuana (1.98% THC)

Experimental

Participants received placebo + low THC marijuana (1.98% THC) on 1 of 5 outpatient sessions in randomized order.

干预措施: Low THC marijuana (Drug)

Placebo + Marijuana (3.56% THC)

Experimental

Participants received placebo + smoked high THC marijuana (3.56 % THC) on 1 of 5 outpatient sessions in randomized order.

干预措施: Placebo capsules (Drug)

Placebo + Marijuana (3.56% THC)

Experimental

Participants received placebo + smoked high THC marijuana (3.56 % THC) on 1 of 5 outpatient sessions in randomized order.

干预措施: High THC marijuana (Drug)

结局指标

主要结局

Pain Tolerance

时间窗: Within each session lasting approximately 5 minutes, for a total of five sessions

Change in pain tolerance from baseline (in seconds) as a function of drug condition. The cold pressor test was administered during each session to examine changes in pain threshold (how many seconds it takes for a participant to begin feeling pain after cold water immersion).

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验